Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of BufferGel and PRO 2000/5 Gel in Men

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: May 16, 2001
Last updated: April 3, 2012
Last verified: April 2012